852 related articles for article (PubMed ID: 24365905)
1. Epidemiological trends in the utilization of bone morphogenetic protein in spinal fusions from 2002 to 2011.
Singh K; Nandyala SV; Marquez-Lara A; Fineberg SJ
Spine (Phila Pa 1976); 2014 Mar; 39(6):491-6. PubMed ID: 24365905
[TBL] [Abstract][Full Text] [Related]
2. Current trends in demographics, practice, and in-hospital outcomes in cervical spine surgery: a national database analysis between 2002 and 2011.
Marquez-Lara A; Nandyala SV; Fineberg SJ; Singh K
Spine (Phila Pa 1976); 2014 Mar; 39(6):476-81. PubMed ID: 24365907
[TBL] [Abstract][Full Text] [Related]
3. Hospital outcomes and complications of anterior and posterior cervical fusion with bone morphogenetic protein.
Fineberg SJ; Ahmadinia K; Oglesby M; Patel AA; Singh K
Spine (Phila Pa 1976); 2013 Jul; 38(15):1304-9. PubMed ID: 23462577
[TBL] [Abstract][Full Text] [Related]
4. Prevalence, complications, and hospital charges associated with use of bone-morphogenetic proteins in spinal fusion procedures.
Cahill KS; Chi JH; Day A; Claus EB
JAMA; 2009 Jul; 302(1):58-66. PubMed ID: 19567440
[TBL] [Abstract][Full Text] [Related]
5. Off-label use of bone morphogenetic proteins in the United States using administrative data.
Ong KL; Villarraga ML; Lau E; Carreon LY; Kurtz SM; Glassman SD
Spine (Phila Pa 1976); 2010 Sep; 35(19):1794-800. PubMed ID: 20700081
[TBL] [Abstract][Full Text] [Related]
6. Epidemiological trends in cervical spine surgery for degenerative diseases between 2002 and 2009.
Oglesby M; Fineberg SJ; Patel AA; Pelton MA; Singh K
Spine (Phila Pa 1976); 2013 Jun; 38(14):1226-32. PubMed ID: 23403550
[TBL] [Abstract][Full Text] [Related]
7. Incidence and risk factors for dysphagia after anterior cervical fusion.
Singh K; Marquez-Lara A; Nandyala SV; Patel AA; Fineberg SJ
Spine (Phila Pa 1976); 2013 Oct; 38(21):1820-5. PubMed ID: 23873236
[TBL] [Abstract][Full Text] [Related]
8. Impact of bone morphogenetic proteins on frequency of revision surgery, use of autograft bone, and total hospital charges in surgery for lumbar degenerative disease: review of the Nationwide Inpatient Sample from 2002 to 2008.
Dagostino PR; Whitmore RG; Smith GA; Maltenfort MG; Ratliff JK
Spine J; 2014 Jan; 14(1):20-30. PubMed ID: 23218827
[TBL] [Abstract][Full Text] [Related]
9. Cerebral vascular accidents after lumbar spine fusion.
Marquez-Lara A; Nandyala SV; Fineberg SJ; Singh K
Spine (Phila Pa 1976); 2014 Apr; 39(8):673-7. PubMed ID: 24384658
[TBL] [Abstract][Full Text] [Related]
10. Does bone morphogenetic protein change the operative nonunion rates in spine fusions?
Guppy KH; Paxton EW; Harris J; Alvarez J; Bernbeck J
Spine (Phila Pa 1976); 2014 Oct; 39(22):1831-9. PubMed ID: 25299166
[TBL] [Abstract][Full Text] [Related]
11. Morbid obesity increases cost and complication rates in spinal arthrodesis.
Kalanithi PA; Arrigo R; Boakye M
Spine (Phila Pa 1976); 2012 May; 37(11):982-8. PubMed ID: 22037526
[TBL] [Abstract][Full Text] [Related]
12. Comparison of perioperative outcomes and cost of spinal fusion for cervical trauma: weekday versus weekend admissions.
Nandyala SV; Marquez-Lara A; Fineberg SJ; Schmitt DR; Singh K
Spine (Phila Pa 1976); 2013 Dec; 38(25):2178-83. PubMed ID: 24285275
[TBL] [Abstract][Full Text] [Related]
13. Spinal fusion for pediatric neuromuscular scoliosis: national trends, complications, and in-hospital outcomes.
Rumalla K; Yarbrough CK; Pugely AJ; Koester L; Dorward IG
J Neurosurg Spine; 2016 Oct; 25(4):500-508. PubMed ID: 27203810
[TBL] [Abstract][Full Text] [Related]
14. Complications after lumbar spine surgery between teaching and nonteaching hospitals.
Nandyala SV; Marquez-Lara A; Fineberg SJ; Hassanzadeh H; Singh K
Spine (Phila Pa 1976); 2014 Mar; 39(5):417-23. PubMed ID: 24573073
[TBL] [Abstract][Full Text] [Related]
15. Perioperative complications and mortality after spinal fusions: analysis of trends and risk factors.
Goz V; Weinreb JH; McCarthy I; Schwab F; Lafage V; Errico TJ
Spine (Phila Pa 1976); 2013 Oct; 38(22):1970-6. PubMed ID: 23928714
[TBL] [Abstract][Full Text] [Related]
16. Use of bone morphogenetic protein among patients undergoing fusion for degenerative diagnoses in the United States, 2002 to 2012.
Martin BI; Lurie JD; Tosteson AN; Deyo RA; Farrokhi FR; Mirza SK
Spine J; 2015 Apr; 15(4):692-9. PubMed ID: 25523380
[TBL] [Abstract][Full Text] [Related]
17. Trends in the treatment of lumbar spine fractures in the United States: a socioeconomics perspective: clinical article.
Baaj AA; Downes K; Vaccaro AR; Uribe JS; Vale FL
J Neurosurg Spine; 2011 Oct; 15(4):367-70. PubMed ID: 21740124
[TBL] [Abstract][Full Text] [Related]
18. Exploratory meta-analysis on dose-related efficacy and morbidity of bone morphogenetic protein in spinal arthrodesis surgery.
Hofstetter CP; Hofer AS; Levi AD
J Neurosurg Spine; 2016 Mar; 24(3):457-75. PubMed ID: 26613283
[TBL] [Abstract][Full Text] [Related]
19. Acute hospital costs after minimally invasive versus open lumbar interbody fusion: data from a US national database with 6106 patients.
Wang MY; Lerner J; Lesko J; McGirt MJ
J Spinal Disord Tech; 2012 Aug; 25(6):324-8. PubMed ID: 21685806
[TBL] [Abstract][Full Text] [Related]
20. Incidence and risk factors for postoperative delirium after lumbar spine surgery.
Fineberg SJ; Nandyala SV; Marquez-Lara A; Oglesby M; Patel AA; Singh K
Spine (Phila Pa 1976); 2013 Sep; 38(20):1790-6. PubMed ID: 23797502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
